It is not recommended to give Reswas Syrup (Levodropropizine 30 mg + Chlorpheniramine Maleate 2 mg) to a child younger than 2 years, including a 1.5-year-old.

⚕️ Safety Information

• Reswas Syrup is generally not recommended for children below 2 years due to potential side effects like drowsiness, dizziness, and blurred vision.
• The syrup contains active ingredients that may have stronger effects in very young children, possibly causing harm or adverse reactions.

🩺 What You Should Do

• Consult a pediatrician before giving this medication to your child.
• The pediatrician can recommend safer alternatives or appropriate dosages based on your child's age and health condition.
• Do not administer this syrup without professional medical approval to avoid risks.

Always seek advice from a pediatric specialist to ensure safe treatment for young children.